Drug-eluting coronary stents: insights from preclinical and pathology studies
10.1038/s41569-019-0234-x · doi-reference
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
10.1136/bmj-2023-078378 · doi-reference
Materials advancements for the safety and patency of implantable cardiovascular devices
10.1007/s12274-024-6808-x · doi-reference
Immuno-regenerative biomaterials for in situ cardiovascular tissue engineering – Do patient characteristics warrant precision engineering?
10.1016/j.addr.2021.113960 · doi-reference
Vascular lesion-specific drug delivery systems: JACC state-of-the-art review
10.1016/j.jacc.2021.03.307 · doi-reference
Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis
10.1186/s12933-023-01962-w · doi-reference
4A tetrahedron system: a synergistic framework for panvascular intervention empowered by flexible electronics
10.1038/s41528-026-00537-5 · doi-reference
The mechanotransduction-immune axis in organ fibrosis: dual regulatory mechanisms and translational therapeutic perspectives
10.3389/fimmu.2025.1670213 · doi-reference
Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation
10.1016/j.atherosclerosis.2016.03.008 · doi-reference
Immunometabolic insights into the foreign body response
10.1126/sciadv.aed8370 · doi-reference
The transcription factor STAT6 mediates direct repression of inflammatory enhancers and limits activation of alternatively polarized macrophages
10.1016/j.immuni.2017.12.010 · doi-reference
Recent advances in silk fibroin-based biomaterials for tissue engineering applications
10.1016/j.ijbiomac.2025.146764 · doi-reference
Immune responses in cardiac repair and regeneration: a comparative point of view
10.1007/s00018-018-2995-5 · doi-reference
Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single de novo coronary lesions in a first-in-human study
10.21037/atm-20-5668 · doi-reference
Mechanical stretch-mediated fibroblast activation: the pivotal role of Piezo1 channels
10.1016/j.bbamcr.2025.120008 · doi-reference
Piezo1-mediated M2 macrophage mechanotransduction enhances bone formation through secretion and activation of transforming growth factor-β1
10.1111/cpr.13440 · doi-reference
Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction
10.1126/sciadv.adc9465 · doi-reference
Mechanosensitive Notch-Dll4 and Klf2-Wnt9 signaling pathways intersect in guiding valvulogenesis in zebrafish
10.1016/j.celrep.2021.109782 · doi-reference
Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces
10.1073/pnas.2003732117 · doi-reference
Impact of endothelial cells on 3D cultured smooth muscle cells in a biomimetic hydrogel
10.1021/am201648f · doi-reference
Foreign body reaction to biomaterials
10.1016/j.smim.2007.11.004 · doi-reference
Fibrin adsorption on cardiovascular biomaterials and medical devices
10.1021/acsabm.2c01057 · doi-reference
Coronary bioresorbable metallic stents: advancements and future perspectives
10.1016/j.jjcc.2024.08.003 · doi-reference
Bio-inspired anisotropic polymeric heart valves exhibiting valve-like mechanical and hemodynamic behavior
10.1007/s40843-019-1217-4 · doi-reference
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
10.4244/eijv9i11a217 · doi-reference
A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model
10.1007/s10554-017-1148-5 · doi-reference
Bioresorbable vascular scaffolds: biodegradation, drug delivery and vascular remodeling
10.1016/j.phrs.2016.03.020 · doi-reference
Prevalence and clinical impact of stent fractures after femoropopliteal stenting
10.1016/j.jacc.2004.11.026 · doi-reference
PIEZO ion channels in cardiovascular functions and diseases
10.1161/circresaha.123.322798 · doi-reference
Flow-induced reprogramming of endothelial cells in atherosclerosis
10.1038/s41569-023-00883-1 · doi-reference
Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels
10.1126/science.1193270 · doi-reference
Role of YAP/TAZ in mechanotransduction
10.1038/nature10137 · doi-reference
Endothelial Krüppel-like factor 2/4: regulation and function in cardiovascular diseases
10.1016/j.cellsig.2025.111699 · doi-reference
A comprehensive evaluation of material properties, degradation kinetics and clinical performance of biodegradable polymer cardiovascular stents: a review
10.1016/j.ijbiomac.2026.150358 · doi-reference
5-year outcomes after bioresorbable coronary scaffolds implanted with improved technique
10.1016/j.jacc.2023.05.003 · doi-reference
Coronary revascularization: a long-term perspective
10.1093/eurheartj/ehaf883 · doi-reference
Fully bioresorbable vascular scaffolds: lessons learned and future directions
10.1038/s41569-018-0124-7 · doi-reference
Acidic extracellular pH promotes accumulation of free cholesterol in human monocyte-derived macrophages via inhibition of ACAT1 activity
10.1016/j.atherosclerosis.2020.08.011 · doi-reference
Dysfunctional high-density lipoprotein cholesterol and coronary artery disease: a narrative review
10.3390/jpm14090996 · doi-reference
The immune system in atherosclerosis
10.1038/ni.2001 · doi-reference
